A NEW MODEL FOR COLLABORATIVE CLINICAL RESEARCH
WE ARE AN INTERNATIONAL, INNOVATIVE, RESEARCH ORGANIZATION IN CLINICAL ONCOLOGY. OUR GOAL IS TO GENERATE THE MOST INNOVATIVE CLINICAL TRIALS WITH THE MOST PROMISING DRUGS BY FOSTERING GLOBAL COLLABORATIONS BETWEEN EXPERT CLINICAL INVESTIGATORS/KOLs AND PHARMACEUTICAL COMPANIES/BIOTECHS.
WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS
MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.
MEDSIR favors a collaborative approach for clinical development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.
TOGETHER WE BUILD A BRIGHTER FUTURE
MEDSIR IN NUMBERS
Some examples of MEDSIR ideas matured into strategic clinical trials.
Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer: A FDG-PET response-adapted strategy
Spanish Lung Liquid vs. Invasive biopsy Program (SLLIP)
Phase II Study of the Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma
Palbociclib with fulvestrant or letrozole for HER-, ER+ metastatic breast cancer